[1] D.E. Tylawsky, H. Kiguchi, J. Vaynshteyn, J. Gerwin, J. Shah, T. Islam, J.A. Boyer, D.R. Boué, M. Snuderl, M.B. Greenblatt, P-selectin-targeted nanocarriers induce active crossing of the blood–brain barrier via caveolin-1-dependent transcytosis, Nat. Mater. 22(3) (2023) 391-399.
[2] B. Huang, T. Tang, S.-H. Chen, H. Li, Z.-J. Sun, Z.-L. Zhang, M. Zhang, R. Cui, Near-infrared-IIb emitting single-atom catalyst for imaging-guided therapy of blood-brain barrier breakdown after traumatic brain injury, Nat. Commun. 14(1) (2023) 197.
[3] Q. Ouyang, Y. Meng, W. Zhou, J. Tong, Z. Cheng, Q. Zhu, New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease, J. Drug Target. 30(1) (2022) 61-81.
[4] B. Tang, W. Zeng, L.L. Song, H.M. Wang, L.Q. Qu, H.H. Lo, L. Yu, A.G. Wu, V.K.W. Wong, B.Y.K. Law, Extracellular vesicle delivery of neferine for the attenuation of neurodegenerative disease proteins and motor deficit in an Alzheimer’s disease mouse model, Pharmaceuticals 15(1) (2022) 83.
[5] L. Séguy, A.-C. Groo, A. Malzert-Freon, How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer’s disease treatment?, Drug Discov. Today 27(6) (2022) 1575-1589.
[6] Q. Mahmood, N.-N. Lu, X.-J. Wang, Y.-Z. Du, M.U. Ghori, B. Tian, H.-Y. Yang, F. Han, G.-J. Jiang, Y.-m.
u, Targeted delivery of β-carotene potentially prevents blood-brain barrier breakdown after stroke in mice, Phytomed. Plus. 3(2) (2023) 100426.
[7] H. Wu, X. Jiang, Y. Li, Y. Dong, J. Zheng, L. Li, Y. Li, J. Wang, X. Lin, X. Zhang, T. Zhang, Z. Gu, J. Gao, Hybrid stem cell-derived bioresponsive vesicles for effective inflamed blood-brain barrier targeting delivery, Nano Today 49 (2023) 101800.
[8] J. Wang, Z. Wang, Y. Li, Y. Hou, C. Yin, E. Yang, Z. Liao, C. Fan, L.L. Martin, D. Sun, Blood brain barrier-targeted delivery of double selenium nanospheres ameliorates neural ferroptosis in Alzheimer's disease, Biomaterials 302 (2023) 122359.
[9] Q. Li, Z. Tang, Y. Zhang, T. Yuan, B. Yuan, L. Du, Y. Jin, Application of low-intensity ultrasound by opening blood–brain barrier for enhanced brain-targeted drug delivery, Int. J. Pharm. 642 (2023) 123191.
[10] A. Pirmoradian, Y. Behshad, F. Sharifi, S. Alipour, L. Jiang, M. Sabzi, Development of antibiotic releasing electrospun nanofibrous mats based on gelatin, Mate. Chem. Horizons 2(3)(2023) 185-193.
[11] H. Zafar, S. Yousefiasl, F. Raza, T-cell membrane-functionalized nanosystems for viral infectious diseases, Mater. Chem. Horizons 2(1) (2023) 41-48.
[12] N. Rabiee, S. Iravani, MXenes and Their Composites: A Versatile Platform for Biomedical Applications, Mater. Chem. Horizons 2(3) (2023) 171-184.
[13] F. Raza, H. Zafar, A.U. Khan, K. Hatami Kahkesh, T-cell membrane-coated nanomaterials in cancer treatment, Mater. Chem. Horizons 1(3) (2022) 199-217.
[14] J. Lopes, D. Lopes, A. Macário-Soares, I. Ferreira-Faria, D. Peixoto, M. Motallebi, I.S. Mohammad, P.S. Giram, P.C. Pires, F. Raza, Cell membrane-coated biomaterials for bone cancer-targeted diagnosis and therapy: a critical update on osteosarcoma applications, Mater. Chem. Horizons 2(1) (2023) 65-79.
[15] K. Hatami Kahkesh, Z. Baghbantaraghdari, D. Jamaledin, F. Dabbagh Moghaddam, N. Kaneko, M. Ghovvati, Synthesis, Characterization, Antioxidant and Antibacterial Activities of Zinc Ferrite and Copper Ferrite Nanoparticles, Mater. Chem. Horizons 2(1) (2023) 49-56.
[16] P. Ganesan, D. Narayanasamy, Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery, Sustain. Chem. Pharm. 6 (2017) 37-56.
[17] S. Nasirizadeh, B. Malaekeh-Nikouei, Solid lipid nanoparticles and nanostructured lipid carriers in oral cancer drug delivery, J. Drug Deliv. Sci. Technol. 55 (2020) 101458.
[18] L. Pan, H. Wang, K. Gu, Nanoliposomes as Vehicles for Astaxanthin: Characterization, In Vitro Release Evaluation and Structure, Molecules 23(11) (2018) 2822.
[19] V.R. Salvi, P. Pawar, Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier, J Drug Deliv. Sci. Technol. 51 (2019) 255-267.
[20] B. Subramaniam, Z.H. Siddik, N.H. Nagoor, Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations, J. Nanopart. Res. 22(6) (2020) 141.
[21] P. Blasi, A. Schoubben, G. Traina, G. Manfroni, L. Barberini, P.F. Alberti, C. Cirotto, M. Ricci, Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity, Int. J. Pharm. 454(1) (2013) 316-323.
[22] T. Fukuta, T. Ishii, T. Asai, A. Sato, T. Kikuchi, K. Shimizu, T. Minamino, N. Oku, Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions, Eur. J. Pharm. Biopharm. 97 (2015) 1-7.
[23] M. Masserini, Nanoparticles for brain drug delivery, Int. Sch. Res. Notices. 2013 (2013).
[24] A. Orthmann, R. Zeisig, R. Süss, D. Lorenz, M. Lemm, I. Fichtner, Treatment of Experimental Brain Metastasis with MTO-Liposomes: Impact of Fluidity and LRP-Targeting on the Therapeutic Result, Pharm. Res. 29(7) (2012) 1949-1959.
[25] S.R. Hwang, K. Kim, Nano-enabled delivery systems across the blood–brain barrier, Archives of Pharmacal Research 37(1) (2014) 24-30.
[26] L. Gastaldi, L. Battaglia, E. Peira, D. Chirio, E. Muntoni, I. Solazzi, M. Gallarate, F. Dosio, Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art, Eur. J. Pharm. Biopharm. 87(3) (2014) 433-444.
[27] S. Harilal, J. Jose, D.G.T. Parambi, R. Kumar, G.E. Mathew, M.S. Uddin, H. Kim, B. Mathew, Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives, J. Pharm. Pharmacol. 71(9) (2019) 1370-1383.
[28] C. Pardeshi, P. Rajput, V. Belgamwar, A. Tekade, G. Patil, K. Chaudhary, A. Sonje, Solid lipid based nanocarriers: an overview, Acta Pharmaceutica 62(4) (2012) 433-472.
[29] Robert D. Bell, Michael D. Ehlers, Breaching the Blood-Brain Barrier for Drug Delivery, Neuron 81(1) (2014) 1-3.
[30] H. Kumar, N. Venkatesh, H. Bhowmik, A. Kuila, Metallic nanoparticle: a review, Biomed. J. Sci. Technol. Res. 4(2) (2018) 3765-3775.
[31] A.K. Mandal, Silver nanoparticles as drug delivery vehicle against infections, Global J. Nanomed. 3(2) (2017) 1-4.
[32] Z. Niu, Y. Li, Removal and Utilization of Capping Agents in Nanocatalysis, Chem. Mater. 26(1) (2014) 72-83.
[33] B. Salesa, P. Ferrús-Manzano, A. Tuñón-Molina, A. Cano-Vicent, M. Assis, J. Andrés, Á. Serrano-Aroca, Study of biological properties of gold nanoparticles: Low toxicity, no proliferative activity, no ability to induce cell gene expression and no antiviral activity, Chem. Biol. Interact. 382 (2023) 110646.
[34] H. Erdoğan, B. Karayavuz, M. Bacanlı, M. Sarper, Ö. Esim, S. Altuntaş, O. Erdem, Y. Özkan, Low-Molecular-Weight Dipeptide Nanogel Containing Plasmonic Gold Nanoparticles for Drug Release Applications, ACS Appl. Nano Mater. 6(8) (2023) 6700-6714.
[35] M. Deinavizadeh, A.R. Kiasat, N. Hooshmand, M. Shafiei, M. Sabaeian, R. Mirzajani, S.M. Zahraei, P. Makvandi, M.A. El-Sayed, NIR/pH Dual-Responsive DOX-Loaded AuNRs@S-β-CD Nanocomposite for Highly Effective Chemo-photothermal Synergistic Therapy against Lung Cancer Cells, J. Phys. Chem. C 126(44) (2022) 18754-18766.
[36] M. Deinavizadeh, A. Kiasat, N. Hooshmand, M. Shafiei, M. Sabaeian, R. Mirzajani, S.M. Zahraei, H.I. Labouta, M.A. El-Sayed, Smart NIR-light and pH responsive doxorubicin-loaded GNRs@SBA-15-SH nanocomposite for chemo-photothermal therapy of cancer, J. Nanophotonics 10(12) (2021) 3303-3319.
[37] M. Deinavizadeh, A.R. Kiasat, N. Hooshmand, H.I. Labouta, M. Shafiei, M. Sabaeian, R. Mirzajani, S.M. Zahraei, P. Makvandi, M.A. El-Sayed, Near-Infrared/pH Dual-Responsive Nanosponges Encapsulating Gold Nanorods for Synergistic Chemo-phototherapy of Lung Cancer, ACS Appl. Nano Mater. 6(18) (2023) 16332-16342.
[38] Q. Duan, R. Liu, J.-Q. Luo, J.-Y. Zhang, Y. Zhou, J. Zhao, J.-Z. Du, Virus-Inspired Glucose and Polydopamine (GPDA)-Coating as an Effective Strategy for the Construction of Brain Delivery Platforms, Nano Lett. 24(1) (2024) 402-410.
[39] J. Kreuter, Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?, Adv. Drug Deliv. Rev. 71 (2014) 2-14.
[40] S. Marrache, R.K. Pathak, S. Dhar, Detouring of cisplatin to access mitochondrial genome for overcoming resistance, Proc. Natl. Acad. Sci. 111(29) (2014) 10444-10449.
[41] K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, W.E. Rudzinski, Biodegradable polymeric nanoparticles as drug delivery devices, J. Control. Release 70(1) (2001) 1-20.
[42] C. Fornaguera, A. Dols-Perez, G. Calderó, M.J. García-Celma, J. Camarasa, C. Solans, PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier, J. Control. Release 211 (2015) 134-143.
[43] L. Escuder-Gilabert, M. Molero-Monfort, R.M. Villanueva-Camañas, S. Sagrado, M.J. Medina-Hernández, Potential of biopartitioning micellar chromatography as an in vitro technique for predicting drug penetration across the blood–brain barrier, J. Chromatogr. B Biomed. Appl. 807(2) (2004) 193-201.
[44] H. Yan, J. Wang, P. Yi, H. Lei, C. Zhan, C. Xie, L. Feng, J. Qian, J. Zhu, W. Lu, C. Li, Imaging brain tumor by dendrimer-based optical/paramagnetic nanoprobe across the blood-brain barrier, Chem. Comm. 47(28) (2011) 8130-8132.
[45] S. Mendiratta, M. Hussein, H.A. Nasser, A.A.A. Ali, Multidisciplinary Role of Mesoporous Silica Nanoparticles in Brain Regeneration and Cancers: From Crossing the Blood–Brain Barrier to Treatment, Part Part. Syst. Charact. 36(9) (2019) 1900195.
[46] T. Dube, S. Chibh, J. Mishra, J.J. Panda, Receptor Targeted Polymeric Nanostructures Capable of Navigating across the Blood-Brain Barrier for Effective Delivery of Neural Therapeutics, ACS Chem. Neurosci. 8(10) (2017) 2105-2117.
[47] I. Wilhelm, I.A. Krizbai, In Vitro Models of the Blood–Brain Barrier for the Study of Drug Delivery to the Brain, Mol. Pharmaceutics 11(7) (2014) 1949-1963.
[48] Z. Jafari, A. Bigham, S. Sadeghi, S.M. Dehdashti, N. Rabiee, A. Abedivash, M. Bagherzadeh, B. Nasseri, H. Karimi-Maleh, E. Sharifi, Nanotechnology-abetted astaxanthin formulations in multimodel therapeutic and biomedical applications, J. Med. Chem. 65(1) (2021) 2-36.
[49] L. Liu, X. Liu, Roles of drug transporters in blood-retinal barrier, Drug Transporters in Drug Disposition, Effects and Toxicity Adv. Exp .Med. Biol. 1141 (2019) 467-504.
[50] X. Wang, B. Song, Z. Wang, L. Qin, W. Liang, The innovative design of a delivery and real-time tracer system for anti-encephalitis drugs that can penetrate the blood-brain barrier, J. Control. Release 363 (2023) 136-148.
[51] X. Yang, W. Yang, X. Xia, T. Lei, Z. Yang, W. Jia, Y. Zhou, G. Cheng, H. Gao, Intranasal delivery of BACE1 siRNA and rapamycin by dual targets modified nanoparticles for Alzheimer's disease therapy, Small 18(30) (2022) 2203182.
[52] P. Poudel, S. Park, Recent advances in the treatment of Alzheimer’s disease using nanoparticle-based drug delivery systems, Pharmaceutics 14(4) (2022) 835.
[53] S. Edavettal, P. Cejudo-Martin, B. Dasgupta, D. Yang, M.D. Buschman, D. Domingo, K. Van Kolen, P. Jaiprasat, R. Gordon, K. Schutsky, Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis, Med 3(12) (2022) 860-882. e15.
[54] L. Wang, Y. Shi, J. Jiang, C. Li, H. Zhang, X. Zhang, T. Jiang, L. Wang, Y. Wang, L. Feng, Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy, Small 18(45) (2022) 2203678.
[55] W. Zhang, N. Kandel, Y. Zhou, N. Smith, B.C. Ferreira, M. Perez, M.L. Claure, K.J. Mintz, C. Wang, R.M. Leblanc, Drug delivery of memantine with carbon dots for Alzheimer’s disease: blood–brain barrier penetration and inhibition of tau aggregation, J. Colloid Interface Sci. 617 (2022) 20-31.
[56] A. Poustforoosh, M.H. Nematollahi, H. Hashemipour, A. Pardakhty, Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-) clinical studies with an emphasis on vesicles, J. Control. Release 343 (2022) 777-797.
[57] N. Shadmani, P. Makvandi, M. Parsa, A. Azadi, K. Nedaei, N. Mozafari, N. Poursina, V. Mattoli, F.R. Tay, A. Maleki, Enhancing methotrexate delivery in the brain by mesoporous silica nanoparticles functionalized with cell-penetrating peptide using in vivo and ex vivo monitoring, Mol. Pharmaceutics 20(3) (2023) 1531-1548.
[58] R. Taliyan, V. Kakoty, K. Sarathlal, S.S. Kharavtekar, C.R. Karennanavar, Y.K. Choudhary, G. Singhvi, Y. Riadi, S.K. Dubey, P. Kesharwani, Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease, J. Control. Release 343 (2022) 528-550.
[59] C. Hernandez, S. Shukla, Liposome based drug delivery as a potential treatment option for Alzheimer's disease, Neural Regen. Res. 17(6) (2022) 1190.
[60] P. Khare, S.X. Edgecomb, C.M. Hamadani, E.E.L. Tanner, D. S Manickam, Lipid nanoparticle-mediated drug delivery to the brain, Adv. Drug Deliv. Rev. 197 (2023) 114861.
[61] M.K. Satapathy, T.-L. Yen, J.-S. Jan, R.-D. Tang, J.-Y. Wang, R. Taliyan, C.-H. Yang, Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB, Pharmaceutics, 2021.
[62] I. Cacciatore, M. Ciulla, E. Fornasari, L. Marinelli, A. Di Stefano, Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases, Expert Opin. Drug Deliv. 13(8) (2016) 1121-1131.
[63] T. Patel, J. Zhou, J.M. Piepmeier, W.M. Saltzman, Polymeric nanoparticles for drug delivery to the central nervous system, Adv. Drug Deliv. Rev. 64(7) (2012) 701-705.
[64] M. Wiranowska, “Advances in the Use of Chitosan and Chlorotoxin- Functionalized Chitosan Polymers in Drug Delivery and Detection of Glioma - A Review", Carbohydr. Polym. (2024) 100427. https://doi.org/10.1016/j.carpta.2024.100427.
[65] M. Shafiq, M. Rafique, Y. Cui, L. Pan, C.-W. Do, E.A. Ho, An insight on ophthalmic drug delivery systems: Focus on polymeric biomaterials-based carriers, J. Control. Release 362 (2023) 446-467.
[66] A. Mishra, R. Kumar, J. Mishra, K. Dutta, P. Ahlawat, A. Kumar, S. Dhanasekaran, A.K. Gupta, S. Sinha, D.K. Bishi, P.K. Gupta, S. Nayak, Strategies facilitating the permeation of nanoparticles through blood-brain barrier: An insight towards the development of brain-targeted drug delivery system, J. Drug Deliv. Sci. Technol. 86 (2023) 104694.
[67] T.O. Lilius, K.N. Mortensen, C. Deville, T.J. Lohela, F.F. Stæger, B. Sigurdsson, E.M. Fiordaliso, M. Rosenholm, C. Kamphuis, F.J. Beekman, A.I. Jensen, M. Nedergaard, Glymphatic-assisted perivascular brain delivery of intrathecal small gold nanoparticles, J. Control. Release 355 (2023) 135-148.
[68] N. Kalčec, N. Peranić, R. Barbir, C.R. Hall, T.A. Smith, M.A. Sani, R. Frkanec, F. Separovic, I. Vinković Vrček, Spectroscopic study of L-DOPA and dopamine binding on novel gold nanoparticles towards more efficient drug-delivery system for Parkinson’s disease, Spectrochim. Acta A Mol. Biomol. 268 (2022) 120707.
[69] F. Dilnawaz, S.K. Sahoo, Therapeutic approaches of magnetic nanoparticles for the central nervous system, Drug Discov. Today 20(10) (2015) 1256-1264.
[70] R. Qiao, C. Fu, H. Forgham, I. Javed, X. Huang, J. Zhu, A.K. Whittaker, T.P. Davis, Magnetic iron oxide nanoparticles for brain imaging and drug delivery, Adv. Drug Deliv. Rev. 197 (2023) 114822.
[71] A. Tomitaka, A. Vashist, N. Kolishetti, M. Nair, Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases, Nanoscale Adv. 5(17) (2023) 4354-4367.
[72] P. Chakraborty, S.S. Das, A. Dey, A. Chakraborty, C. Bhattacharyya, R. Kandimalla, B. Mukherjee, A.V. Gopalakrishnan, S.K. Singh, S. Kant, P. Nand, S. Ojha, P. Kumar, N.K. Jha, S.K. Jha, S. Dewanjee, Quantum dots: The cutting-edge nanotheranostics in brain cancer management, J. Control. Release 350 (2022) 698-715.
[73] P. Hassanzadeh, Towards the quantum-enabled technologies for development of drugs or delivery systems, J. Control. Release 324 (2020) 260-279.
[74] H. Yukawa, K. Sato, Y. Baba, Theranostics applications of quantum dots in regenerative medicine, cancer medicine, and infectious diseases, Adv. Drug Deliv. Rev. 200 (2023) 114863.
)
)